The overall goals ofthe Administrative Core are to provide leadership and the organizational backbone for this proposal, promote collaboration between the projects and cores, and coordinate interactions with external entities such as the National Heart, Lung, and Blood Institute (NHLBI) and the Food and Drug Administration (FDA). To accomplish these goals, we propose specific tasks listed below. Specific Task 1: To facilitate communication among Projects 1-3 and Cores A and B and to assist all projects in manuscript preparation and submission as well as assist scientists in registering manuscripts on PubMed Central. Specific Task 2: To provide mechanisms for communication between the University of Wisconsin, NHLBI, and internal and external project reviewers. Specific Task 3: To provide regulatory support to all projects and cores through interactions with the University of Wisconsin Health Sciences Institution Review Board (IRB) and the FDA. The Administrative Core will interact with all projects and cores in this proposal through organization, notification, and distribution of meeting minutes of monthly internal project review meetings. The Administrative Core will oversee the rate of subject accrual to ensure that each project is able to meet its required sample size. The core will be responsible for preparation and submission of annual progress reports to the Institute and will organize external and internal reviews as needed. Finally, the core will work with the FDA with regard to an Investigational New Drug (IND) application for the proposed use of segmental bronchoprovocation with allergen using house dust mite, cat, or ragweed allergen.
The overall objective of this core is to provide administrative support for the entire program project grant. By providing this support, each project and remaining core can focus on completing research for their proposed scientific questions to meet the overall goal of this grant.
|Wilkerson, Emily M; Johansson, Mats W; Hebert, Alexander S et al. (2016) The Peripheral Blood Eosinophil Proteome. J Proteome Res 15:1524-33|
|Shen, Zhong-Jian; Hu, Jie; Shiizaki, Kazuhiro et al. (2016) Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1. PLoS One 11:e0150093|
|Esnault, Stephane; Johansson, Mats W; Kelly, Elizabeth A et al. (2016) IL-3 Up-regulates and Activates Human Eosinophil CD32 and Î±MÃŸ2 Integrin Causing Degranulation. Clin Exp Allergy :|
|Olson, Ashleigh A; Evans, Michael D; Johansson, Mats W et al. (2016) Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults. Ann Allergy Asthma Immunol 117:387-393.e2|
|Mathur, Sameer K; Fichtinger, Paul S; Evans, Michael D et al. (2016) Variability of blood eosinophil count as an asthma biomarker. Ann Allergy Asthma Immunol 117:551-553|
|Esnault, Stephane; Kelly, Elizabeth A; Sorkness, Ronald L et al. (2016) Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients. J Allergy Clin Immunol 137:767-73.e6|
|Zheng, M; Turton, K B; Zhu, F et al. (2016) A mix of S and Î”S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture. Oncogenesis 4:e184|
|Kelly, Elizabeth A; Esnault, Stephane; Johnson, Sean H et al. (2016) Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. Immunol Cell Biol 94:701-8|
|Metcalfe, Dean D; Pawankar, Ruby; Ackerman, Steven J et al. (2016) Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ J 9:7|
|Shen, Zhong-Jian; Malter, James S (2015) XBP1, a determinant of the eosinophil lineage. Nat Immunol 16:793-4|
Showing the most recent 10 out of 79 publications